Z-N-Methyl-D-valine | CAS:53978-73-7

We serve Z-N-Methyl-D-valine CAS:53978-73-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Z-N-Methyl-D-valine

CAS No: 53978-73-7
Product Name: Z-N-Methyl-D-valine
Other Name:
Z-N-Methyl-D-valine
(2R)-3-methyl-2-[methyl(phenylmethoxycarbonyl)amino]butanoic acid
N-[(Benzyloxy)carbonyl]-N-methyl-D-valine
Z-D-N-Me-Val-OH
Z-N-Methyl-D-valine
D-Benzyloxycarbonyl-N-methyl-valin
(R)-2-(((Benzyloxy)carbonyl)(methyl)amino)-3-methylbutanoic acid
N-Methyl-N-Cbz-D-valine
N-Cbz-N-methyl-D-valine
 
Density: 1.2±0.1 g/cm3
Boiling Point: 407.1±34.0 °C at 760 mmHg
Molecular Formula: C14H19NO4
Molecular Weight: 265.305
Flash Point: 200.0±25.7 °C
Exact Mass: 265.131409
PSA: 66.84000
LogP: 3.08
Appearance of Characters: Solid | White to off-white
Vapour Pressure: 0.0±1.0 mmHg at 25°C
Index of Refraction: 1.533
 
Specification
Appearance: White to off-white Solid
Assay: ≥98.0%
 
Application
Amino Acid Derivatives. Be used as pharmaceutical intermediates.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like Z-N-Methyl-D-valine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Cbz-N-methyl-D-valine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Z-N-Methyl-D-valine Use and application,N-[(Benzyloxy)carbonyl]-N-methyl-D-valine technical grade,usp/ep/jp grade.


Related News: Advanced clinical trials with the Company’s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.Isocyanic acid 3,4-dichlorophenyl ester manufacturer Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.Methyl N-(2-chlorophenyl)glycinate hydrochloride (1:1) supplier The company’s short-term plan is to move from a purely chemical intermediate manufacturer to a formula active material supplier, and its long-term goal is to become a solution provider in the selected segment. In the future, this business is expected to become a new growth point for the company’s profit.Rabeprazole Sulfide vendor Wuhan’s local transport networks – including bus, subway and ferries – were suspended from 10am on 23 January, and airport and train stations closed to outgoing passengers.The CTSuccess service uses Catalent’s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.